Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Expenses:    
General and Administrative $ 1,269,458 $ 1,664,791
Research and Development 438,283 707,928
Executive Severance 0 962,833
Change in Fair Value of Contingent Consideration 208,926 233,890
Total Operating Expenses 1,916,667 3,569,442
Operating Loss (1,916,667) (3,569,442)
Other Income, Net:    
Gain on Disposal of Fixed Assets 0 4,211
Interest Income, Net 33,465 217
Other Income, Net 14,666 0
Total Other Income, Net 48,131 4,428
Net Loss $ (1,868,536) $ (3,565,014)
Net Loss per Common Share - Basic (in usd per share) $ (1.00) $ (11.27)
Net Loss per Common Share - Diluted (in usd per share) $ (1.00) $ (11.27)
Weighted Average Shares Outstanding - Basic (in shares) 1,863,466 316,379
Weighted Average Shares Outstanding - Diluted (in shares) 1,863,466 316,379
Other Comprehensive Loss:    
Net Loss $ (1,868,536) $ (3,565,014)
Foreign Currency Translation Adjustments (32,671) 27,839
Comprehensive Loss $ (1,901,207) $ (3,537,175)